FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196384162> ?p ?o ?g. }

• W3196384162 abstract "To investigate associations between isoniazid for latent tuberculosis and risk of severe hepatitis, affecting patients with rheumatoid arthritis or ankylosing spondylitis whose treatment includes tumor necrosis factor inhibitors. Our self-controlled case series study analyzed Taiwan's National Health Insurance Database from 2003 to 2015 to identify RA or AS patients, aged ≥ 20 years, receiving TNF inhibitors and a 9-month single isoniazid treatment. The outcome of interest was hospitalization due to severe hepatitis. We defined risk periods by isoniazid exposure (days): 1-28, 29-56, 57-84, 85-168, 169-252, and 253-280. To compare risk of severe hepatitis in exposed and non-exposed periods, we performed conditional Poisson regressions to generate incidence rate ratios (IRR) and 95% confidence intervals, with adjustment of patients' baseline covariates including age, sex, HBV, HCV and related medication. Of 54,267 RA patients and 137,889 AS patients identified between 2000 and 2015, 11,221 (20.7%) RA and 4,208 (3.1%) AS patients underwent TNFi therapy, with 722 (5%) receiving isoniazid for latent tuberculosis. We identified 31 incident cases (4.3%) of hospitalization due to severe hepatitis. Of these hospitalization events, 5 occurred in the exposed periods, 25 occurred in the INH unexposed periods, and 1 occurred in the pre-exposure period. Compared with non-exposure, the risk of severe hepatitis was higher in exposed periods (incidence rate ratio [IRR]: 5.1, 95% CI: 1.57-16.55), especially 57-84 days (IRR: 17.29, 95% CI: 3.11-96.25) and 85-168 days (IRR:10.55, 95% CI: 1.90-58.51). The INH related fatal hepatotoxicity was not identified in our study. Our findings suggest an association between risk of severe hepatitis and exposure to isoniazid in patients with RA or AS under TNFi therapy, particularly within the exposed period 57-168 days. A close monitoring of liver function is mandatory to minimize the risk, especially within the first 6 months after initiation of 9 months isoniazid." @default.
• W3196384162 created "2021-09-13" @default.
• W3196384162 creator A5003470205 @default.
• W3196384162 creator A5009838697 @default.
• W3196384162 creator A5037135870 @default.
• W3196384162 creator A5039111017 @default.
• W3196384162 creator A5045147067 @default.
• W3196384162 creator A5047815639 @default.
• W3196384162 creator A5075654077 @default.
• W3196384162 date "2021-09-09" @default.
• W3196384162 modified "2023-09-27" @default.
• W3196384162 title "Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors" @default.
• W3196384162 cites W1827623663 @default.
• W3196384162 cites W1969671825 @default.
• W3196384162 cites W1969761834 @default.
• W3196384162 cites W1978464644 @default.
• W3196384162 cites W1982348729 @default.
• W3196384162 cites W2000542384 @default.
• W3196384162 cites W2007006833 @default.
• W3196384162 cites W2013829686 @default.
• W3196384162 cites W2013962941 @default.
• W3196384162 cites W2028777217 @default.
• W3196384162 cites W2030772677 @default.
• W3196384162 cites W2035068437 @default.
• W3196384162 cites W2038535814 @default.
• W3196384162 cites W2058837954 @default.
• W3196384162 cites W2064727915 @default.
• W3196384162 cites W2082800864 @default.
• W3196384162 cites W2083908345 @default.
• W3196384162 cites W2091419870 @default.
• W3196384162 cites W2096020283 @default.
• W3196384162 cites W2097427535 @default.
• W3196384162 cites W2107408002 @default.
• W3196384162 cites W2123147014 @default.
• W3196384162 cites W2131999276 @default.
• W3196384162 cites W2142004396 @default.
• W3196384162 cites W2148232746 @default.
• W3196384162 cites W2156662512 @default.
• W3196384162 cites W2159112035 @default.
• W3196384162 cites W2192908242 @default.
• W3196384162 cites W2519433651 @default.
• W3196384162 cites W2556522911 @default.
• W3196384162 cites W2596243402 @default.
• W3196384162 cites W2602321146 @default.
• W3196384162 cites W2607130235 @default.
• W3196384162 cites W26625382 @default.
• W3196384162 cites W2724422679 @default.
• W3196384162 cites W2791049593 @default.
• W3196384162 cites W2807695141 @default.
• W3196384162 cites W2886632226 @default.
• W3196384162 cites W3049033558 @default.
• W3196384162 cites W4231972505 @default.
• W3196384162 doi "https://doi.org/10.1038/s41598-021-97444-8" @default.
• W3196384162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8429453" @default.
• W3196384162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34504225" @default.
• W3196384162 hasPublicationYear "2021" @default.
• W3196384162 type Work @default.
• W3196384162 sameAs 3196384162 @default.
• W3196384162 citedByCount "1" @default.
• W3196384162 countsByYear W31963841622023 @default.
• W3196384162 crossrefType "journal-article" @default.
• W3196384162 hasAuthorship W3196384162A5003470205 @default.
• W3196384162 hasAuthorship W3196384162A5009838697 @default.
• W3196384162 hasAuthorship W3196384162A5037135870 @default.
• W3196384162 hasAuthorship W3196384162A5039111017 @default.
• W3196384162 hasAuthorship W3196384162A5045147067 @default.
• W3196384162 hasAuthorship W3196384162A5047815639 @default.
• W3196384162 hasAuthorship W3196384162A5075654077 @default.
• W3196384162 hasBestOaLocation W31963841621 @default.
• W3196384162 hasConcept C120665830 @default.
• W3196384162 hasConcept C121332964 @default.
• W3196384162 hasConcept C126322002 @default.
• W3196384162 hasConcept C142724271 @default.
• W3196384162 hasConcept C167704817 @default.
• W3196384162 hasConcept C2775876817 @default.
• W3196384162 hasConcept C2776029263 @default.
• W3196384162 hasConcept C2776967927 @default.
• W3196384162 hasConcept C2777402515 @default.
• W3196384162 hasConcept C2777575956 @default.
• W3196384162 hasConcept C2777975735 @default.
• W3196384162 hasConcept C2779806340 @default.
• W3196384162 hasConcept C2781069245 @default.
• W3196384162 hasConcept C2908647359 @default.
• W3196384162 hasConcept C44249647 @default.
• W3196384162 hasConcept C61511704 @default.
• W3196384162 hasConcept C71924100 @default.
• W3196384162 hasConcept C73269764 @default.
• W3196384162 hasConcept C99454951 @default.
• W3196384162 hasConceptScore W3196384162C120665830 @default.
• W3196384162 hasConceptScore W3196384162C121332964 @default.
• W3196384162 hasConceptScore W3196384162C126322002 @default.
• W3196384162 hasConceptScore W3196384162C142724271 @default.
• W3196384162 hasConceptScore W3196384162C167704817 @default.
• W3196384162 hasConceptScore W3196384162C2775876817 @default.
• W3196384162 hasConceptScore W3196384162C2776029263 @default.
• W3196384162 hasConceptScore W3196384162C2776967927 @default.
• W3196384162 hasConceptScore W3196384162C2777402515 @default.
• W3196384162 hasConceptScore W3196384162C2777575956 @default.
• W3196384162 hasConceptScore W3196384162C2777975735 @default.
• W3196384162 hasConceptScore W3196384162C2779806340 @default.

• next